152813-69-9Relevant academic research and scientific papers
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N′-[3-(tetrazol-5-ylamino)phenyl]ureas
Castro, José L.,Ball, Richard G.,Broughton, Howard B.,Russell, Michael G. N.,Rathbone, Denise,Watt, Alan P.,Baker, Raymond,Chapman, Kerry L.,Fletcher, Alan E.,Patel, Smita,Smith, Alison J.,Marshall, George R.,Ryecroft, Wayne,Matassa, Victor G.
, p. 842 - 849 (2007/10/03)
The design, synthesis, and biological activity of a novel series of CCK-B receptor antagonists (1) which incorporate a tetrazol-5-ylamino functionality attached to the phenyl ring of the arylurea moiety of L-365,260 are described. In these compounds, the
